Physician

Madhava Rao Kanakamedala, M.D.,

According to 2025 Medicare claims, Madhava Kanakamedala, M.D., (NPI: 1013158013) practices radiation oncology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79124-2167.

Kanakamedala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 180 traditional Medicare patients, billed 5,757 HCPCS/CPT codes, and received $846,294 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 89 prescription claims across 49 beneficiaries totaling $1,138 in drug costs, led by Dexamethasone (Dexamethasone). Open Payments data shows 1 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $27,332 to $846,294. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $214 and ending at $1,138. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$470K$941K2015 Medicare payment: $27,332 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $31,586 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $74,780 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $70,492 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $53,316 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $902,757 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $836,851 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $807,490 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $940,991 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $846,294 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201565446$27,332
201663508$31,586
20171251,236$74,780
20181151,148$70,492
201988605$53,316
20201375,213$902,757
20211485,013$836,851
20221575,307$807,490
20231745,374$940,991
20241805,757$846,294

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1K$2.2K2018 Drug cost: $214 (USD; Tot_Drug_Cst)2020 Drug cost: $1,505 (USD; Tot_Drug_Cst)2021 Drug cost: $1,464 (USD; Tot_Drug_Cst)2022 Drug cost: $1,065 (USD; Tot_Drug_Cst)2023 Drug cost: $2,152 (USD; Tot_Drug_Cst)2024 Drug cost: $1,138 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181113$214
2019N/RN/RN/R
20203475$1,505
20213081$1,464
20224177$1,065
202351101$2,152
20244989$1,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions80327$145
77263Complex radiation therapy planning95105$124
77334Design and construction of complex radiation treatment device94182$94
77336Continuing radiation therapy consultation per week90345$66
77300Calculation of radiation therapy dose79241$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DexamethasoneDexamethasone18361$323
SsdSilver Sulfadiazine12250$128
Pantoprazole SodiumPantoprazole Sodium12720$37

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$33Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Madhava Rao Kanakamedala, M.D., ?

Tedicare shows public-source Medicare data for Madhava Rao Kanakamedala, M.D., (NPI 1013158013), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Madhava Rao Kanakamedala, M.D., have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Madhava Rao Kanakamedala, M.D., ?

Madhava Rao Kanakamedala, M.D., is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Madhava Rao Kanakamedala, M.D., have Open Payments data?

Madhava Rao Kanakamedala, M.D., has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.